rxstatShortages › Bumetanide

Bumetanide shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Bumetanide has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 2
Reports on file
3

Reports by product

Resolved
BURINEX
1MG · TABLET · KARO PHARMA AB
DIN 00728284 · ended May 31, 2024 · Shortage of an active ingredient.
Resolved
BURINEX
5MG · TABLET · KARO PHARMA AB
DIN 00728276 · ended Apr 23, 2023 · Delay in shipping of the drug.
Resolved
BURINEX
5MG · TABLET · KNIGHT THERAPEUTICS INC.
DIN 00728276 · ended Oct 25, 2019 · Delay in shipping of the drug.

What's happening

There are no active shortage reports for Bumetanide. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Bumetanide is classified under “HIGH-CEILING DIURETICS” (ATC C03CA).

Recent changes

Common questions

When will Bumetanide be back in stock in Canada?

Bumetanide has no active shortage; supply is normal per Health Canada reports.

Why is Bumetanide in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (high-ceiling diuretics)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.